Brian C. Kelly PhD, Associate Professor, Brooke E. Wells PhD, Research Scientist, Mark Pawson MA, Project Manager, Amy LeClair MA, Participant Coordinator, Jeffrey T. Parsons PhD, Distinguished Professor, Sarit A. Golub, Associate Professor.
Novel psychoactive drug use among younger adults involved in US nightlife scenes
Article first published online: 24 JUN 2013
© 2013 Australasian Professional Society on Alcohol and other Drugs
Drug and Alcohol Review
Volume 32, Issue 6, pages 588–593, November 2013
How to Cite
Kelly, B. C., Wells, B. E., Pawson, M., Leclair, A., Parsons, J. T. and Golub, S. A. (2013), Novel psychoactive drug use among younger adults involved in US nightlife scenes. Drug and Alcohol Review, 32: 588–593. doi: 10.1111/dar.12058
- Issue published online: 12 NOV 2013
- Article first published online: 24 JUN 2013
- Manuscript Accepted: 20 MAY 2013
- Manuscript Received: 12 MAR 2013
- National Institute on Drug Abuse. Grant Number: R01DA025081
- National Institute on Child Health & Human Development. Grant Number: R01HD061410
- synthetic cannabinoid;
- young adult
Introduction and Aims
The emergence of novel psychoactive substances has been reported in clinical studies and recent studies of users. The use of these substances in European nightlife scenes is well documented. Little research has been done to identify the prevalence of these drugs among young adults active in other regions. We focus our sample on socially active young adults to gain an indication of the prevalence and understanding of demographic factors associated with past year mephedrone (‘meph’, ‘bath salts’) and synthetic cannabinoid (‘spice’, ‘K2’) use.
Design and Methods
This study reports on the results of a field-based survey of 1740 patrons at nightlife venues in New York City.
Within the sample, 8.2% reported use of synthetic cannabinoids and 1.1% reported the use of mephedrone. Gay and bisexual men reported higher prevalence of mephedrone use. Latinos reported higher prevalence of synthetic cannabinoid use. Multivariate analyses indicate that sexual minority identity is associated with mephedrone use and younger age and Latino ethnicity are associated with synthetic cannabinoid use.
Discussion and Conclusion
The findings suggest that the use of synthetic cannabinoids and mephedrone among adults in US nightlife scenes remains relatively low in comparison with European nightlife scenes, and is low relative to other drug use among young people within these scenes. [Kelly BC, Wells BE, Pawson M, LeClair A, Parsons JT, Golub SA. Novel psychoactive drug use among younger adults involved in US nightlife scenes. Drug Alcohol Rev 2013;32:588–593]